You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALXN2050

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial in Ruddington (ALXN2050 MR Prototype Tablet, ALXN2050 Immediate Release (IR) Tablet, ALXN2050 MR

Not yet recruiting
  • Healthy Participants
  • ALXN2050 MR Prototype Tablet
  • +2 more
  • Ruddington, Nottinghamshire, United Kingdom
    Quotient Science Ltd
Mar 13, 2023

Healthy Trial in Lincoln ([14C]-ALXN2050)

Completed
  • Healthy
  • Lincoln, Nebraska
    Clinical Trial Site
Jan 23, 2023

Healthy Adult Participants Trial in Baltimore (Treatment A, Treatment B, Treatment C)

Completed
  • Healthy Adult Participants
  • Treatment A
  • +2 more
  • Baltimore, Maryland
    Baltimore Parexel EPCU
Jan 19, 2023

Healthy Trial in Tempe (ALXN2050, Fluconazole, Rifampin)

Completed
  • Healthy
  • ALXN2050
  • +2 more
  • Tempe, Arizona
    Clinical Trial Site
Dec 7, 2022

Renal Impairment, Healthy Trial in Hialeah, Orlando (ALXN2050)

Completed
  • Renal Impairment
  • Healthy
  • ALXN2050
  • Hialeah, Florida
  • +1 more
Oct 12, 2022

Impaired Hepatic Function, Healthy Trial in Hialeah, Orlando (ALXN2050)

Recruiting
  • Impaired Hepatic Function
  • Healthy
  • ALXN2050
  • Hialeah, Florida
  • +1 more
May 11, 2022

Healthy Trial in Tempe (ALXN2050, ALXN2050-matching Placebo, Moxifloxacin)

Completed
  • Healthy
  • ALXN2050
  • +3 more
  • Tempe, Arizona
    Clinical Trial Site
Dec 9, 2021

Healthy Trial in Tempe (ALXN2050, Placebo)

Completed
  • Healthy
  • ALXN2050
  • Placebo
  • Tempe, Arizona
    Clinical Trial Site
Dec 9, 2021

Healthy Participants Trial (Vemircopan, Rosuvastatin, Metformin)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Oct 2, 2023

Healthy Trial in Auckland (ALXN2050, Placebo)

Completed
  • Healthy
  • ALXN2050
  • Placebo
  • Auckland, New Zealand
    Clinical Trial Site
Sep 9, 2021

Healthy Trial in Auckland (ALXN2050, Placebo)

Completed
  • Healthy
  • ALXN2050
  • Placebo
  • Auckland, New Zealand
    Clinical Trial Site
Sep 9, 2021

Healthy Trial in Lincoln (ACH-0145228: Immediate Release, ACH-0145228: Powder-in-capsule)

Completed
  • Healthy
  • ACH-0145228: Immediate Release
  • ACH-0145228: Powder-in-capsule
  • Lincoln, Nebraska
    Clinical Trial Site
Dec 8, 2021

Generalized Myasthenia Gravis, Myasthenia Gravis Trial in Worldwide (ALXN2050, Placebo)

Recruiting
  • Generalized Myasthenia Gravis
  • Myasthenia Gravis
  • ALXN2050
  • Placebo
  • Phoenix, Arizona
  • +45 more
Dec 15, 2022

Lupus Nephritis, Immunoglobulin A Nephropathy, IgAN Trial in United States (ALXN2050, Placebo)

Recruiting
  • Lupus Nephritis
  • +3 more
  • ALXN2050
  • Placebo
  • Huntsville, Alabama
  • +49 more
Jan 25, 2023

Healthy Trial in Tempe (ACH-0145228, Midazolam, Digoxin)

Completed
  • Healthy
  • Tempe, Arizona
    Clinical Study Site
Jan 12, 2021

Wilson Disease Trial in Worldwide (ALXN1840, SoC Therapy)

Active, not recruiting
  • Wilson Disease
  • Los Angeles, California
  • +53 more
May 2, 2022

Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Ravulizumab)

Active, not recruiting
  • Neuromyelitis Optica
  • Neuromyelitis Optica Spectrum Disorder
  • Ravulizumab
  • Birmingham, Alabama
  • +67 more
Feb 3, 2022

Amyotrophic Lateral Sclerosis, ALS Trial in Worldwide (Placebo, Ravulizumab)

Terminated
Has Results
  • Amyotrophic Lateral Sclerosis
  • ALS
  • Placebo
  • Ravulizumab
  • Phoenix, Arizona
  • +94 more
Dec 15, 2022